Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novavax Inc NVAX

Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID... see more

Recent & Breaking News (NDAQ:NVAX)

NOVAVAX to Present at the 15th Annual Bio CEO & Investor Conference

Troy Schwensen February 7, 2013

BARDA Continues Novavax' Influenza Vaccine Programs Following In-Process Review

Troy Schwensen January 24, 2013

Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013

Marketwired January 14, 2013

H1N1-related stocks rise as pandemic declared

Buzz on the Boards June 11, 2009

Swine flu-related stocks end the day down: update

Stockhouse Editorial April 29, 2009

Noveko board buzzing on swine flu, share price

Buzz on the Boards April 29, 2009